Milan, Italy

Elisabetta Frattini



Average Co-Inventor Count = 2.4

ph-index = 1


Company Filing History:


Years Active: 2021-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Elisabetta Frattini: Innovator in Pharmaceutical Compositions

Introduction

Elisabetta Frattini is a prominent inventor based in Milan, Italy. She has made significant contributions to the field of pharmaceutical compositions, particularly through her innovative patents. With a total of 2 patents, her work focuses on enhancing the efficacy of various formulations.

Latest Patents

Frattini's latest patents include "Powder solid dispersions comprising quercetin, process for their preparation and formulations thereof." This patent discloses powder solid dispersions that include quercetin, phospholipids, and a very freely water-soluble carrier. It also outlines a process for preparing these powder solid dispersions, along with pharmaceutical, nutraceutical, and cosmetic compositions that incorporate them. Another notable patent is "Process for the preparation of powder compositions," which reveals a method for creating powder compositions that include a lipophilic extract and phospholipids. This patent also describes the use of these powder compositions in preventing and treating inflammatory and painful states.

Career Highlights

Elisabetta Frattini is associated with Indena S.p.A., a company known for its expertise in the development of plant-based ingredients for the pharmaceutical and nutraceutical industries. Her work at Indena has allowed her to focus on innovative solutions that address health-related challenges.

Collaborations

Frattini collaborates with esteemed colleagues such as Massimo Ronchi and Antonella Riva. These partnerships enhance her research and development efforts, contributing to the advancement of her innovative projects.

Conclusion

Elisabetta Frattini is a trailblazer in the field of pharmaceutical compositions, with her patents reflecting her commitment to innovation. Her work continues to impact the industry positively, paving the way for new therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…